Ligand Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified, and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation, and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management, and commercialization) to ultimately generate Ligand revenue.
Ligand Pharmaceuticals has raised $625M across 1 funding round on record, the most recent an undisclosed round of $625M announced in Jun 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ligand Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Ligand Pharmaceuticals Funding Rounds
Ligand Pharmaceuticals Founders and Leadership Team
Contact details for the Ligand Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Ligand Pharmaceuticals Funding Compared to Other Biotechnology Startups
Ligand Pharmaceuticals' latest round of $625M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ligand Pharmaceuticals in Biotechnology and San Diego
Companies Similar to Ligand Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Ligand Pharmaceuticals Funding FAQs
What does Ligand Pharmaceuticals do?
Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified, and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation, and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management, and commercialization) to ultimately generate Ligand revenue.
How much funding has Ligand Pharmaceuticals raised?
Ligand Pharmaceuticals has raised $625M across 1 round on record. The most recent is an undisclosed round of $625M announced in Jun 2026.
When did Ligand Pharmaceuticals last raise funding?
Ligand Pharmaceuticals' most recent funding round on record is an undisclosed round of $625M, announced in Jun 2026.
Who founded Ligand Pharmaceuticals?
FundedIQ lists Todd Davis (Founder) at Ligand Pharmaceuticals.
Where is Ligand Pharmaceuticals headquartered?
Ligand Pharmaceuticals is based in San Diego, California, United States.
How many employees does Ligand Pharmaceuticals have?
Ligand Pharmaceuticals is in the 11-50 employee band.
How does Ligand Pharmaceuticals' funding compare to other Biotechnology startups?
Ligand Pharmaceuticals' latest round of $625M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Ligand Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ligand Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.